This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Androgen-targeted therapy in men with prostate cancer: evolving practice and future considerations
Prostate Cancer and Prostatic Diseases Open Access 21 August 2018
Access options
Subscribe to this journal
Receive 12 print issues and online access
$189.00 per year
only $15.75 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to the full article PDF.
USD 39.95
Prices may be subject to local taxes which are calculated during checkout
References
National Comprehensive Cancer Network. Changing the course of prostate cancer treatment: life expectancy estimation, active surveillance, and drug development. National Comprehensive Cancer Network [online], (2014)
Rights and permissions
About this article
Cite this article
NCCN guidelines for prostate cancer updated. Nat Rev Urol 12, 63 (2015). https://doi.org/10.1038/nrurol.2014.350
Published:
Issue date:
DOI: https://doi.org/10.1038/nrurol.2014.350
This article is cited by
-
Androgen-targeted therapy in men with prostate cancer: evolving practice and future considerations
Prostate Cancer and Prostatic Diseases (2019)
-
The impact of local treatment of the primary tumor site in node positive and metastatic prostate cancer patients
Prostate Cancer and Prostatic Diseases (2017)